BILDYOS DIN 02565943
Status: Approved
Holder: SHANGHAI HENLIUS BIOTECH, INC.
Health Canada record
| Active ingredient(s) | DENOSUMAB 60 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION; SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | M05BX04 DENOSUMAB |
|---|
| Original market date | |
|---|
| Current status date | 09-Mar-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Shanghai Henlius Biologics Co. Ltd. — licence , not currently licensed, last inspection rating C (2025-04-02).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DENOSUMAB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02565951 | BILDYOS | SHANGHAI HENLIUS BIOTECH, INC. | Solution | DENOSUMAB 60 MG | Marketed |
| 02567679 | BOMYNTRA | FRESENIUS KABI CANADA LTD | Solution | DENOSUMAB 120 MG | Approved |
| 02567687 | BOMYNTRA | FRESENIUS KABI CANADA LTD | Solution | DENOSUMAB 120 MG | Approved |
| 02567253 | BOSAYA | BIOCON BIOLOGICS CANADA INC | Solution | DENOSUMAB 60 MG | Approved |
| 02567660 | CONEXXENCE | FRESENIUS KABI CANADA LTD | Solution | DENOSUMAB 60 MG | Approved |
| 02566265 | DENOZA | APOTEX INC | Solution | DENOSUMAB 60 MG | Marketed |
| 02566273 | IDENOS | APOTEX INC | Solution | DENOSUMAB 120 MG | Approved |
| 02545411 | JUBBONTI | SANDOZ CANADA INCORPORATED | Solution | DENOSUMAB 60 MG | Marketed |
| 02567482 | OBODENCE | SAMSUNG BIOEPIS CO., LTD | Solution | DENOSUMAB 60 MG | Approved |
| 02569787 | ODENSIFY | JAMP PHARMA CORPORATION | Solution | DENOSUMAB 60 MG | Approved |
| 02560895 | OSENVELT | CELLTRION INC. | Solution | DENOSUMAB 120 MG | Marketed |
| 02343541 | PROLIA | AMGEN CANADA INC | Solution | DENOSUMAB 60 MG | Marketed |
| 02570750 | QOSEQU | MANTRA PHARMA INC | Solution | DENOSUMAB 60 MG | Approved |
| 02560917 | STOBOCLO | CELLTRION INC. | Solution | DENOSUMAB 60 MG | Marketed |
| 02566001 | TUZEMTY | SHANGHAI HENLIUS BIOTECH, INC. | Solution | DENOSUMAB 120 MG | Marketed |
| 02567261 | VEVZUO | BIOCON BIOLOGICS CANADA INC | Solution | DENOSUMAB 120 MG | Approved |
| 02545764 | WYOST | SANDOZ CANADA INCORPORATED | Solution | DENOSUMAB 120 MG | Marketed |
| 02566923 | XBRYK | SAMSUNG BIOEPIS CO., LTD | Solution | DENOSUMAB 120 MG | Approved |
| 02569795 | XDENO | JAMP PHARMA CORPORATION | Solution | DENOSUMAB 120 MG | Approved |
| 02368153 | XGEVA | AMGEN CANADA INC | Solution | DENOSUMAB 120 MG | Marketed |
| 02343568 | PROLIA | AMGEN CANADA INC | Solution | DENOSUMAB 60 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 37095 | 2026-03-09 | New Drug Submission (NDS) | |
Request a quote for BILDYOS
How to read a Canadian DIN record